Early-Onset Colorectal Adenocarcinoma in the IDEA Database: Treatment Adherence, Toxicities, and Outcomes With 3 and 6 Months of Adjuvant Fluoropyrimidine and Oxaliplatin.

MLA

Fontana, Elisa, et al. “Early-Onset Colorectal Adenocarcinoma in the IDEA Database: Treatment Adherence, Toxicities, and Outcomes With 3 and 6 Months of Adjuvant Fluoropyrimidine and Oxaliplatin.” Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology, vol. 39, no. 36, Dec. 2021, pp. 4009–19. EBSCOhost, https://doi.org/10.1200/JCO.21.02008.

APA

Fontana, E., Meyers, J., Sobrero, A., Iveson, T., Shields, A. F., Taieb, J., Yoshino, T., Souglakos, I., Smyth, E. C., Lordick, F., Moehler, M., Giraut, A., Harkin, A., Labianca, R., Meyerhardt, J., André, T., Boukovinas, I., Lonardi, S., Saunders, M., … Shi, Q. (2021). Early-Onset Colorectal Adenocarcinoma in the IDEA Database: Treatment Adherence, Toxicities, and Outcomes With 3 and 6 Months of Adjuvant Fluoropyrimidine and Oxaliplatin. Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology, 39(36), 4009–4019. https://doi.org/10.1200/JCO.21.02008

Chicago

Fontana, Elisa, Jeff Meyers, Alberto Sobrero, Timothy Iveson, Anthony F Shields, Julien Taieb, Takayuki Yoshino, et al. 2021. “Early-Onset Colorectal Adenocarcinoma in the IDEA Database: Treatment Adherence, Toxicities, and Outcomes With 3 and 6 Months of Adjuvant Fluoropyrimidine and Oxaliplatin.” Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology 39 (36): 4009–19. doi:10.1200/JCO.21.02008.